Skip to search.
 FTSE 100 Up 0.42%
Streaming
Ticker Tape: On

KaloBios Pharmaceuticals, Inc. (KBIO)

-NasdaqGM
2.38 Down 0.02(0.83%) 20:09 - Nasdaq Real Time Price
Add to Portfolio
Prev Close:2.40
Open:2.44
Bid:2.32 x 200
Ask:2.33 x 200
1y Target Est:7.50
Beta:-0.002
Next Earnings Date:N/A
Day's Range:2.30 - 2.44
52wk Range:2.09 - 6.55
Volume:65,021
Avg Vol (3m):375,477
Market Cap:78.49m
P/E (ttm):N/A
EPS (ttm):-1.73
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
KBIODown 0.83%78.49m
VRTXDown 1.14%15.60b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1,798.96
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.54
Quarterly EPS Est (Mar-14) :-0.38
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

KaloBios Pharmaceuticals, Inc., a biopharmaceutical company, primarily develops monoclonal antibody therapeutics for the treatment of respiratory diseases and cancer in the United States. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback